Skip to main content
Toggle navigation
Login
Search
Home
Tweets by IDWeek 2023
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
On Demand
Back
Favorite
Facebook
Tweet
Print
Bradford J. Gessner, M.D., M.P.H.
Vice President Global Medical Lead for Respiratory Vaccines
Pfizer Biopharma Group
Poster(s):
(260) Durability of Antibody Responses to RSV in Older Adults Following Hospitalization for Acute Respiratory Infection
Thursday, October 12, 2023
12:15 PM – 1:30 PM
US ET
(888) Estimation of the Incidence of RSV-attributable Circulatory and Respiratory Hospital Admissions in Adults in Germany between 2015–2019, Overall and for Specific Conditions
Thursday, October 12, 2023
12:15 PM – 1:30 PM
US ET
(892) Epidemiology, clinical features, and outcomes of Rhinovirus/Enterovirus in older adults hospitalized with acute respiratory infections and those with CHF and COPD exacerbations
Thursday, October 12, 2023
12:15 PM – 1:30 PM
US ET
(1149) Contribution of
S.pneumoniae
Serotypes in Adults with Invasive Pneumococcal Disease (IPD) and Pneumococcal Community-acquired Pneumonia (pCAP)
Friday, October 13, 2023
12:15 PM – 1:30 PM
US ET
(2604) Contact With School-Aged Children is a Major Risk Factor for Pneumococcal Colonization in Older Adults
Saturday, October 14, 2023
12:15 PM – 1:30 PM
US ET
(2621) Social Risk Factors for RSV-related Hospitalizations in Adults ≥ 50 years of age
Saturday, October 14, 2023
12:15 PM – 1:30 PM
US ET
(2629)
Estimation of Hospitalization and Mortality Burden of RSV in Adults in Spain between 2015–2019
Saturday, October 14, 2023
12:15 PM – 1:30 PM
US ET